This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Italian rules for parapharmacies appear not to breach EU competition law, EU court suggests

( March 12, 2015, 10:54 GMT | Official Statement) -- MLex Summary: The EU’s highest court has said it found no indications of breaches of EU rules governing the abuse of a dominant position or a monopoly, in response to questions referred from an Italian court. The regional administrative court in Sicily wanted to know whether national legislation that prohibits parapharmacies from selling prescription drugs — whose cost cannot be claimed back from the public healthcare system — is in line with EU competition rules. Today’s advice was made in a non-binding opinion issued by EU Court of Justice Advocate General Nils Wahl.The AG Opinion in C-497/12 - Gullotta and Farmacia di Gullotta Davide & C. is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections